Oddo BHF Asset Management Sas acquired a new stake in shares of Genpact Limited (NYSE:G - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 33,741 shares of the business services provider's stock, valued at approximately $1,323,000.
A number of other large investors have also bought and sold shares of the company. Dimensional Fund Advisors LP raised its holdings in Genpact by 34.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,326,054 shares of the business services provider's stock valued at $107,065,000 after acquiring an additional 847,249 shares during the period. Pzena Investment Management LLC increased its holdings in Genpact by 130.3% during the 2nd quarter. Pzena Investment Management LLC now owns 1,163,870 shares of the business services provider's stock worth $37,465,000 after acquiring an additional 658,560 shares during the period. Los Angeles Capital Management LLC purchased a new stake in shares of Genpact in the third quarter worth $19,779,000. Tandem Investment Advisors Inc. purchased a new stake in shares of Genpact in the 3rd quarter valued at about $17,025,000. Finally, Geode Capital Management LLC lifted its position in Genpact by 12.6% during the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider's stock valued at $148,142,000 after purchasing an additional 413,646 shares during the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other Genpact news, CEO Balkrishan Kalra sold 9,000 shares of Genpact stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $46.40, for a total value of $417,600.00. Following the completion of the transaction, the chief executive officer now directly owns 267,404 shares of the company's stock, valued at approximately $12,407,545.60. The trade was a 3.26 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.80% of the company's stock.
Genpact Stock Down 0.1 %
Shares of NYSE G traded down $0.06 during mid-day trading on Friday, hitting $44.67. 913,785 shares of the stock traded hands, compared to its average volume of 1,348,975. The company has a market cap of $7.88 billion, a price-to-earnings ratio of 12.27, a PEG ratio of 1.56 and a beta of 1.18. The stock has a fifty day moving average price of $42.38 and a 200-day moving average price of $37.78. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $47.98. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85.
Genpact Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 23rd. Shareholders of record on Monday, December 9th will be paid a dividend of $0.1525 per share. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date of this dividend is Monday, December 9th. Genpact's dividend payout ratio is 16.76%.
Analysts Set New Price Targets
G has been the topic of a number of research reports. TD Cowen raised their price objective on Genpact from $40.00 to $45.00 and gave the company a "hold" rating in a report on Friday, November 8th. Robert W. Baird boosted their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a report on Friday, November 8th. JPMorgan Chase & Co. increased their target price on shares of Genpact from $35.00 to $43.00 and gave the company a "neutral" rating in a report on Friday, September 6th. Needham & Company LLC boosted their price target on shares of Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a research note on Monday, November 11th. Finally, Jefferies Financial Group upped their price target on shares of Genpact from $35.00 to $40.00 and gave the company a "hold" rating in a research report on Monday, September 9th. Eight research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $42.33.
View Our Latest Stock Analysis on G
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.